Products Categories
CAS No.: | 652-78-8 |
---|---|
Name: | Gossypin |
Article Data: | 1 |
Molecular Structure: | |
Formula: | C21H20O13 |
Molecular Weight: | 480.382 |
Synonyms: | 2-(3,4-Dihydroxyphenyl)-8-(beta-D-glucopyranosyloxy)-3,5,7-trihydroxy-4H-1-benzopyran-4-one;3,5,7,8,3',4'-Hexahydroxyflavone-8-glucoside;Gossypetin-8-glucoside; |
Density: | 1.883 g/cm3 |
Melting Point: | 229-230 ºC |
Boiling Point: | 886 °C at 760 mmHg |
Flash Point: | 310.8 °C |
Hazard Symbols: | XiXn |
Risk Codes: | 36/37/38-62-37/38-36-22 |
Safety: | 26-36-37 |
PSA: | 230.74000 |
LogP: | -0.83330 |
gossypin
Conditions | Yield |
---|---|
With hydrogenchloride In ethanol at 70℃; for 1h; |
furfural
gossypin
2-(9-(2-furyl)-4,5-dihydroxy-7-(3,5,7-trihydroxy-8-{(3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-2-pyranyl)oxy}-4-oxo-4H-2-chromenyl)-9H-2-xanthenyl)-3,5,7-trihydroxy-8-{(3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-2-pyranyl)oxy}-4H-4-chromenone
Conditions | Yield |
---|---|
With iron(III) chloride at 130 - 140℃; |
thiophene-2-carbaldehyde
gossypin
2-(4,5-dihydroxy-9-(2-thienyl)-7-(3,5,7-trihydroxy-8-{(3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-2-pyranyl)oxy}-4-oxo-4H-2-chromenyl)-9H-2-xanthenyl)-3,5,7-trihydroxy-8-{(3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-2-pyranyl)oxy}-4H-4-chromenone
Conditions | Yield |
---|---|
With iron(III) chloride at 130 - 140℃; |
4-nitrobenzaldehdye
gossypin
2-(4,5-dihydroxy-9-(4-nitrophenyl)-7-(3,5,7-trihydroxy-8-{(3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-2-pyranyl)oxy}-4-oxo-4H-2-chromenyl)-9H-2-xanthenyl)-3,5,7-trihydroxy-8-{(3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-2-pyranyl)oxy}-4H-4-chromenone
Conditions | Yield |
---|---|
With iron(III) chloride at 130 - 140℃; |
benzaldehyde
gossypin
2-(4,5-dihydroxy-9-phenyl-7-(3,5,7-trihydroxy-8-{(3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-2-pyranyl)oxy}-4-oxo-4H-2-chromenyl)-9H-2-xanthenyl)-3,5,7-trihydroxy-8-{(3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-2-pyranyl)oxy}-4H-4-chromenone
Conditions | Yield |
---|---|
With iron(III) chloride at 130 - 140℃; |
4-hydroxy-benzaldehyde
gossypin
2-(4,5-dihydroxy-9-(4-hydroxyphenyl)-7-(3,5,7-trihydroxy-8-{(3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-2-pyranyl)oxy}-4-oxo-4H-2-chromenyl)-9H-2-xanthenyl)-3,5,7-trihydroxy-8-{(3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-2-pyranyl)oxy}-4H-4-chromenone
Conditions | Yield |
---|---|
With iron(III) chloride at 130 - 140℃; |
4-methoxy-benzaldehyde
gossypin
2-(4,5-dihydroxy-9-(4-methoxyphenyl)-7-(3,5,7-trihydroxy-8-{(3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-2-pyranyl)oxy}-4-oxo-4H-2-chromenyl)-9H-2-xanthenyl)-3,5,7-trihydroxy-8-{(3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-2-pyranyl)oxy}-4H-4-chromenone
Conditions | Yield |
---|---|
With iron(III) chloride at 130 - 140℃; |
salicylaldehyde
gossypin
2-(4,5-dihydroxy-9-(2-hydroxyphenyl)-7-(3,5,7-trihydroxy-8-{(3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-2-pyranyl)oxy}-4-oxo-4H-2-chromenyl)-9H-2-xanthenyl)-3,5,7-trihydroxy-8-{(3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-2-pyranyl)oxy}-4H-4-chromenone
Conditions | Yield |
---|---|
With iron(III) chloride at 130 - 140℃; |
meta-hydroxybenzaldehyde
gossypin
2-(4,5-dihydroxy-9-(3-hydroxyphenyl)-7-(3,5,7-trihydroxy-8-{(3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-2-pyranyl)oxy}-4-oxo-4H-2-chromenyl)-9H-2-xanthenyl)-3,5,7-trihydroxy-8-{(3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-2-pyranyl)oxy}-4H-4-chromenone
Conditions | Yield |
---|---|
With iron(III) chloride at 130 - 140℃; |
With CAS Registry Number 652-78-8, Gossypin is also can be called 2-(3,4-Dihydroxyphenyl)-8-(beta-D-glucopyranosyloxy)-3,5,7-trihydroxy-4H-1-benzopyran-4-one ; 3,5,7,8,3',4'-Hexahydroxyflavone-8-glucoside ; Gossypetin-8-glucoside ,and its IUPAC Name is 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one . It belongs to the product category of flavanols.
Properties of Gossypin: (1)Index of Refraction: 1.799; (2)Molar Refractivity: 109.02 cm3; (3)Molar Volume: 255 cm3; (4)Surface Tension: 127.8 dyne/cm; (5)Density: 1.883 g/cm3; (6)Flash Point: 310.8 °C ; (7)Melting Point: 229-230 °C; (8)Enthalpy of Vaporization: 134.9 kJ/mol; (9)Boiling Point: 886 °C at 760 mmHg; (10)Vapour Pressure: 1.18E-33 mmHg at 25 °C.
A study investigated that percutaneous administration of SM induces oxidative stress and gossypin can protect it as a prophylactic agent by intraperitoneal or oral routes. Both gossypin and suramin inhibited (P<0.001) compound 48/80-induced systemic anaphylaxis reactions, antiprurities (P<0.001) and reduced the histamine release in rats. Further, both showed significant (P<0.001) protection against rat peritoneal mast cells activated by compound 48/80. Thus, our findings provide evidence that gossypin and suramin inhibit mast cell-derived allergic reactions. In addition, another study shows that the influence of gossypin on the development of acute tolerance to morphine was investigated using acetic acid induced writhing assay procedure in mice. Gossypin pre-treatment significantly attenuated the acute tolerance development to morphine induce antinociceptive response. All these evidences suggest that the therapeutic potential of gossypin as a substitute to morphine.
When you are using Gossypin, please be cautious about it as the following:
First: Wear suitable protective clothing and gloves because it is irritating to eyes, respiratory system and skin. And Gossypin is risk of impaired fertility and harmful if swallowed, so you should in case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
The toxicity of Gossypin as the following:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
guinea pig | LD50 | intravenous | 26300ug/kg (26.3mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 9, Pg. 647, 1959. | |
rat | LD50 | intraperitoneal | 2240mg/kg (2240mg/kg) | Indian Journal of Pharmacology. Vol. 10, Pg. 277, 1978. | |
rat | LD50 | intravenous | 125mg/kg (125mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 9, Pg. 647, 1959. |